Fertility Drug and Surgery Market Trends, Regional Analysis, Growth, Share, Top Companies Forecast

Market Synopsis:

The fertility drug and surgery market trends is expected to reach USD 2.21 billion by 2030 at 9.50% CAGR during the forecast period 2022-2030.The rates of infertility are getting higher, which has encouraged massive investments in the research & development of effective drugs and surgeries. Market Research Future (MRFR) has highlighted in its latest analysis that the global fertility drug and surgery market is projected to expand at a CAGR of 9.8% during the projection period of 2018 to 2023.

Infertility diseases affect both men and women. Treatments have been developed for both the genders and drug research is expected to constantly drive the expansion of the fertility drug and surgery market over the next couple of years. In addition, rising working population of women has led to increased cases of late pregnancies. This, in turn, is prognosticated to boost the revenue creation of the fertility drug and surgery market over the next couple of years. 

Obesity is also a significant factor driving the growth of the market. Increasing burden of obesity has led to an exponential increase in the prevalence of infertility. It is projected to catapult the global fertility drug and surgery market on an upward trajectory over the forecast period. Other factors such as increasing disposable income, rising healthcare expenditure, etc. are poised to influence the market positively. However, on the flip side, factors such as high treatment cost and complications associated with surgeries is anticipated to restrict market growth over the next few years.

Market Segmentation:

Based on the underlying cause, the global fertility drug and surgery market has been segmented into male and female.

By drug, the fertility drug and surgery market has been segmented into letrozole, Serophene, clomiphene citrate, hormone treatment, gonadotrophins estrogen receptor modulators, aromatase inhibitors, dopamine agonists, metformin hydrochloride, and others.

Depending on the procedures, the global fertility drug and surgery market has been segmented into laparoscopy and robotic laparoscopy, hysteroscopy, laparotomy/open surgery, varicocelectomy, vasectomy reversal (vasovasostomy or vasoepididymostomy), egg retrieval, sperm retrieval (epididymal aspiration).

Based on end-user, the fertility drug and surgery market has been segmented into hospitals, clinical research institutes, fertility clinics, and others.

Regional Analysis:

A detailed geographical analysis of the global fertility drug and surgery market report has been included in this MRFR report which covers four major regions – Americas, Asia Pacific, Europe, and the Middle East & Africa (MEA). Americas is likely to lead the expansion of the market on account of the increasing rate of infertility in the region. Rising prevalence of obesity and increasing cases of delayed pregnancies are anticipated to catapult the global fertility drug and surgery market on upward trajectory in the years to come. Europe held the second leading position in 2017. It has been studied in this report that the riding prevalence of sexually transmitted diseases is responsible for increasing infertility rate in the region. On the other hand, Asia Pacific fertility drug and surgery market is poised to exhibit immense developments. Factors such as rising awareness, availability of healthcare services, etc. are projected to boost revenue growth of the fertility drug and surgery market in the region over the next few years.

Competitive Dashboard:

The key players participating in the landscape of the global fertility drug and surgery market are Eli Lilly, Baxter Healthcare Corporation, Ferring Pharmaceuticals, Inc., Merck & Co. Pharmaceutical Company, Noven Pharmaceuticalorganon, Inc., Janssen Pharmaceuticals Inc., Personal Products Company, Pfizer, Inc., Procter & Gamble Pharmaceuticals, and Emd Serono, Inc. Growth strategies are expected to e executed by these players that are poised to boost revenue creation in the market over the next couple of years. Few of these strategies are mergers & acquisitions, collaborations, partnerships, etc. Investments are also anticipated to be injected in the future trajectory of the fertility drug and surgery market for gaining edge over competitors.

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Comments

Post a Comment

Popular posts from this blog

Hair Removal Devices Market Competitive Landscape And Regional Forecast To 2027

Overview: The global report on the hair removal devices market reveals that the market is expected to take a leap from its previous valuation of USD 915.2 million in 2017 with a 8.8% CAGR during the forecast period of 2018 to 2023. Market Research Future (MRFR) considers several factors like fashion, sports, cultural practices, military, medical reasons, and others as prominent growth-inducing avenues for the market. The easy availability of these products through retail and e-commerce lines strongly denotes hair removal devices market trends and better awareness regarding the product can boost the market prospect. Get Sample Report @   https://www.marketresearchfuture.com/sample_request/7323 Competitive Landscape: The global  hair removal devices market  growth can benefit substantially from various companies like Sciton, Inc, Alma Lasers, Ltd., Syneron Medical Ltd., Cutera Inc., Cynosure, Inc., Lynton Lasers Ltd, Solta Medical Inc., Strata Skin Sciences, Inc., Lumenis L...
Read more

The Evolving Landscape of Pompe Disease Treatment: A Regional Overview of the Online Market

Pompe disease, a rare and debilitating genetic disorder, has seen significant advancements in treatment options over the years. This article provides a regional overview of the online Pompe disease treatment market , shedding light on the latest developments and the global perspective on managing this condition. Understanding Pompe Disease Pompe disease, also known as glycogen storage disease type II, is an autosomal recessive disorder caused by a deficiency of the enzyme acid alpha-glucosidase (GAA). This deficiency leads to the accumulation of glycogen in various tissues, primarily affecting muscles, including the heart and respiratory muscles. It is a rare condition with an estimated incidence of 1 in 40,000 to 1 in 300,000 births, depending on the population. Global Market Overview The global Pompe disease treatment market has witnessed substantial growth in recent years, driven by advancements in therapies and increasing awareness about the disease. The market comprises va...
Read more

Ulcerative Colitis Market Key Opinion Leaders | Market Performance and Forecast by 2027

Market Overview As per the reports published by Market Research Future (MRFR), the worldwide ulcerative colitis market has been recorded as a growing market. The market can be estimated to generate remarkable worth in the coming future. Ulcerative colitis is a category of inflammatory bowel disease (IBD) that mostly impacts the lower region of the body such as the rectum and sigmoid colon. Diarrhea, bleeding from the rectum, belly pain, and cramps are some of the common signs of  ulcerative colitis market . As per the studies conducted by the Centers for Disease Control, global prevalence of ulcerative colitis has been recorded to be witnessing 0.5 to 24.5 cases per 100,000 people every year. Chances of recurrence of the ailment’s signs is also high. The Colitis Foundation of America stated that almost 30% of people on remission are likely to suffer from the ailment seethe in the future, right after the cure and remission. Market Segmentation Global ulcerative colitis market has be...
Read more